Affiliation:
1. Tulane University
2. University of Oklahoma Health Sciences Center
3. Department of Biomedical Engineering, Tulane University
Abstract
Abstract
Accurate prognosis for cancer patients can provide critical information for optimizing treatment plans and improving life quality. Combining omics data and demographic/clinical information can offer a more comprehensive view of cancer prognosis than using omics or clinical data alone and can reveal the underlying disease mechanisms at the molecular level. In this study, we developed a novel deep learning framework to extract information from high-dimensional gene expression and miRNA expression data and conduct prognosis prediction for breast cancer and ovarian cancer patients. Our model achieved significantly better prognosis prediction than the conventional Cox Proportional Hazard model and other competitive deep learning approaches in various settings. Moreover, an interpretation approach was applied to tackle the “black-box” nature of deep neural networks and we identified features (i.e., genes, miRNA, demographic/clinical variables) that made important contributions to distinguishing predicted high- and low-risk patients. The identified associations were partially supported by previous studies.
Publisher
Research Square Platform LLC
Reference69 articles.
1. Cox-nnet: an artificial neural network method for prognosis prediction of high-throughput omics data;Ching T;PLoS computational biology,2018
2. Cancer statistics, 2022;Siegel RL;CA Cancer J Clin,2022
3. Simple prognostic model for patients with advanced cancer based on performance status;Jang RW;Journal of Oncology Practice,2014
4. Machine learning applications in cancer prognosis and prediction;Kourou K;Computational and structural biotechnology journal,2015
5. Automated model versus treating physician for predicting survival time of patients with metastatic cancer;Gensheimer MF;Journal of the American Medical Informatics Association,2021